Encompass Health
About: Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Employees: 27,297
0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
228% more call options, than puts
Call options by funds: $15.9M | Put options by funds: $4.85M
13% more funds holding in top 10
Funds holding in top 10: 8 [Q2] → 9 (+1) [Q3]
10% more capital invested
Capital invested by funds: $8.27B [Q2] → $9.13B (+$855M) [Q3]
4% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 48
0% more funds holding
Funds holding: 475 [Q2] → 477 (+2) [Q3]
1.88% less ownership
Funds ownership: 95.86% [Q2] → 93.98% (-1.88%) [Q3]
14% less repeat investments, than reductions
Existing positions increased: 168 | Existing positions reduced: 196
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$110
16%
upside
Avg. target
$114
20%
upside
High target
$117
24%
upside
5 analyst ratings
5 positive
100%
0 neutral
0%
0 negative
0%
RBC Capital Ben Hendrix 25% 1-year accuracy 18 / 71 met price target | 16%upside $110 | Outperform Maintained | 30 Oct 2024 |
Truist Securities David Macdonald 56% 1-year accuracy 49 / 87 met price target | 23%upside $116 | Buy Reiterated | 30 Oct 2024 |
Barclays Andrew Mok 29% 1-year accuracy 18 / 62 met price target | 23%upside $116 | Overweight Maintained | 29 Oct 2024 |
Keybanc Matthew Gillmor 27% 1-year accuracy 3 / 11 met price target | 24%upside $117 | Overweight Maintained | 29 Oct 2024 |
UBS Andrew Mok 29% 1-year accuracy 18 / 62 met price target | 16%upside $110 | Buy Maintained | 25 Sept 2024 |
Financial journalist opinion
Based on 12 articles about EHC published over the past 30 days
Positive
Zacks Investment Research
23 hours ago
Encompass Health (EHC) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Neutral
Zacks Investment Research
1 day ago
Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?
The Healthcare sector sees volume growth and improved occupancy while battling rising medical costs and regulatory uncertainty.
Neutral
PRNewsWire
3 days ago
Encompass Health Announces Preliminary Plans to Build a 50-bed Inpatient Rehabilitation Hospital in Bangor
BIRMINGHAM, Ala. and BANGOR, Maine , Dec. 18, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital to be located at 1017 Union Street in Bangor, Maine.
Positive
Zacks Investment Research
1 week ago
Should Value Investors Buy Encompass Health (EHC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Neutral
Zacks Investment Research
1 week ago
EHC or CHE: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Encompass Health (EHC) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
Positive
Zacks Investment Research
2 weeks ago
Here's Why Encompass Health (EHC) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Neutral
Business Wire
2 weeks ago
Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners
BIRMINGHAM, Ala. & DALLAS--(BUSINESS WIRE)--On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit. The Court awarded judgment against private equity firms Vistria Group and Nautic Partners and the home health and hospice business now known as VitalCar.
Neutral
PRNewsWire
2 weeks ago
Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners
BIRMINGHAM, Ala., and DALLAS , Dec. 4, 2024 /PRNewswire/ -- On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit.
Positive
Zacks Investment Research
3 weeks ago
Encompass Health Up 60% in a Year: What Lies Ahead for Investors?
EHC remains well-poised for growth on the back of solid discharge growth, an aging U.S. population, frequent expansion initiatives and strong cash reserves.
Positive
Zacks Investment Research
3 weeks ago
Why Is Encompass Health (EHC) Up 3.8% Since Last Earnings Report?
Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock?
Charts implemented using Lightweight Charts™